You are here : Home > The Institute > Research Themes > Biomedical Imaging > Inumac Iseult

Imaging of Neuro Disease using High Field MR and Contrastophores





Published on 27 June 2018

The project Inumac (Imaging of Neuro disease Using high field MR and Contrastophores) or Iseult in french, is led by French-German consortium. It is aimed at pushing the frontiers of medical imaging using high field magnetic resonance and novel contrast agents and develops a unique MRI scanner for human imaging operating at 11.7T and its applications.

The project was initiated in 2006 with an overall budget of €200 million, including €80 million in public funding. The project is structured for five years and it  involves  the University of Freiburg (Germany), Siemens Medical Solutions (Germany), Bruker BioSpin GmbH (Germany), the French Commissariat à l'énergie atomique (CEA, France), Guerbet (France) and Alstom (France).


3 objectives: 

  • To build a MRI system with high field (11,7T) for human. The system is planned to be installed at NeuroSpin in 2016
  • To improve the  high field magnetic resonance imaging (MRI)
  • To develop novel contrast agents (done in June 2012)

At the CEA, this project is a collaboration between:

  • NeuroSpin, carrier of the contrast agent project and 11.7T MRI project
  • The IRFU, in charge of the construction of the superconducting magnet and the MRI antenna

Strategic pilot: Denis Le Bihan
Operational pilot: Cécile Lerman